Liver cirrhosis.
Ginès P, Krag A, Abraldes JG, Solà E, Fabrellas N, Kamath PS.
Lancet. 2021 Oct 9;398(10308):1359-1376. doi: 10.1016/S0140-6736(21)01374-X. Epub 2021 Sep 17.
Liver cirrhosis.
Tsochatzis EA, Bosch J, Burroughs AK.
Lancet. 2014 May 17;383(9930):1749-61. doi: 10.1016/S0140-6736(14)60121-5. Epub 2014 Jan 28.
Clinical states of cirrhosis and competing risks.
D'Amico G, Morabito A, D'Amico M, Pasta L, Malizia G, Rebora P, Valsecchi MG.
J Hepatol. 2018 Mar;68(3):563-576. doi: 10.1016/j.jhep.2017.10.020. Epub 2017 Oct 27.
Application of ultrasound for the diagnosis of cirrhosis/portal hypertension.
Han SK, Kim MY, Kang SH, Baik SK.
J Med Ultrason (2001). 2022 Jul;49(3):321-331. doi: 10.1007/s10396-022-01191-w. Epub 2022 Feb 18.
Liver fibrosis.
Bataller R, Brenner DA.
J Clin Invest. 2005 Feb;115(2):209-18. doi: 10.1172/JCI24282.
Predicting portal thrombosis in cirrhosis: Some issues.
Dai CY, Chuang WL, Yu ML.
J Hepatol. 2022 Jan;76(1):224-225. doi: 10.1016/j.jhep.2021.08.015. Epub 2021 Aug 27.
Haemostatic alterations and management of haemostasis in patients with cirrhosis.
Lisman T, Caldwell SH, Intagliata NM.
J Hepatol. 2022 Jun;76(6):1291-1305. doi: 10.1016/j.jhep.2021.11.004.
Cyclic GMP in Liver Cirrhosis-Role in Pathophysiology of Portal Hypertension and Therapeutic Implications.
Kreisel W, Lazaro A, Trebicka J, Grosse Perdekamp M, Schmitt-Graeff A, Deibert P.
Int J Mol Sci. 2021 Sep 26;22(19):10372. doi: 10.3390/ijms221910372.
Cystic Fibrosis-related cirrhosis.
Leung DH, Narkewicz MR.
J Cyst Fibros. 2017 Nov;16 Suppl 2:S50-S61. doi: 10.1016/j.jcf.2017.07.002.
[Recent Research Advance to Differentiate Portal Hypertension Associated with Primary Myelofibrosis and Cirrhosis --Review].
Li R, Liu HS, Chen Y.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Apr;31(2):598-601. doi: 10.19746/j.cnki.issn.1009-2137.2023.02.043.
